Q&A: Regeneron Founder – and UVA M.D./Ph.D. Alum – Discusses COVID-19 Treatment

Image
Dr. Leonard Schleifer discusses the company’s successful COVID-19 monoclonal antibody treatment ahead of a talk at UVA on Friday.

Dr. Leonard Schleifer discusses the company’s successful COVID-19 monoclonal antibody treatment ahead of a talk at UVA on Friday.

UVAToday
https://news.virginia.edu/content/qa-regeneron-founder-and-uva-mdphd-alum-discu…